X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14) 14
index medicus (14) 14
female (13) 13
glioblastoma (11) 11
male (11) 11
middle aged (11) 11
oncology (11) 11
adult (10) 10
medicine & public health (9) 9
survival (9) 9
aged (8) 8
analysis (8) 8
clinical neurology (8) 8
glioblastoma multiforme (8) 8
dna methylation (7) 7
temozolomide (7) 7
bevacizumab (6) 6
brain neoplasms - genetics (6) 6
prognosis (6) 6
radiotherapy (6) 6
tumors (6) 6
brain cancer (5) 5
brain neoplasms - mortality (5) 5
brain neoplasms - pathology (5) 5
chemotherapy (5) 5
genetic aspects (5) 5
glioblastoma - mortality (5) 5
gliomas (5) 5
neurology (5) 5
patients (5) 5
young adult (5) 5
cancer (4) 4
glioblastoma - genetics (4) 4
glioblastoma - pathology (4) 4
glioma - genetics (4) 4
malignant gliomas (4) 4
mutation (4) 4
radiation therapy (4) 4
surgery (4) 4
aged, 80 and over (3) 3
astrocytoma (3) 3
brain neoplasms - drug therapy (3) 3
brain neoplasms - therapy (3) 3
brain research (3) 3
care and treatment (3) 3
combined modality therapy (3) 3
dacarbazine - analogs & derivatives (3) 3
disease progression (3) 3
disease-free survival (3) 3
dna, neoplasm - genetics (3) 3
gene (3) 3
gene deletion (3) 3
gene expression (3) 3
genomics (3) 3
glioblastoma - drug therapy (3) 3
glioma (3) 3
hematology (3) 3
isocitrate dehydrogenase - genetics (3) 3
magnetic resonance imaging (3) 3
medical prognosis (3) 3
mgmt (3) 3
motivation (3) 3
neoplasm grading (3) 3
promoter regions, genetic (3) 3
resection (3) 3
tumor suppressor proteins - genetics (3) 3
animals (2) 2
antiangiogenic therapy (2) 2
antineoplastic agents, alkylating - therapeutic use (2) 2
astrocytoma - genetics (2) 2
brain neoplasms - diagnosis (2) 2
cancer therapies (2) 2
cell line, tumor (2) 2
cell survival (2) 2
classification (2) 2
concomitant (2) 2
dacarbazine - therapeutic use (2) 2
deoxyribonucleic acid--dna (2) 2
dna modification methylases - genetics (2) 2
dna repair enzymes - genetics (2) 2
expression (2) 2
follow-up studies (2) 2
gene frequency (2) 2
genes, tumor suppressor (2) 2
genotype (2) 2
glioblastoma - diagnosis (2) 2
glioblastoma - surgery (2) 2
glioblastoma - therapy (2) 2
glioma - pathology (2) 2
idh mutations (2) 2
irinotecan (2) 2
long-term survival (2) 2
malignant glioma (2) 2
medical colleges (2) 2
medicine (2) 2
medicine, research & experimental (2) 2
methylation (2) 2
mice (2) 2
multiforme (2) 2
mutation - genetics (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 87, Issue 5, pp. 1094 - 1099
Purpose Pseudoprogression (PP) during adjuvant treatment of glioblastoma (GBM) is frequent and is a clinically and radiologically challenging problem. While... 
Radiology | Hematology, Oncology and Palliative Medicine | BIOMARKER | ONCOLOGY | CONCOMITANT | IDH MUTATIONS | MALIGNANT GLIOMAS | RADIOTHERAPY | HIGH-GRADE GLIOMAS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PROGRESSION | TEMOZOLOMIDE | Dacarbazine - therapeutic use | Humans | Middle Aged | Brain Neoplasms - pathology | DNA Repair Enzymes - genetics | Male | Brain Neoplasms - metabolism | DNA Methylation | Glioblastoma - genetics | Gene Deletion | Tumor Suppressor Proteins - genetics | DNA Repair Enzymes - metabolism | Dacarbazine - analogs & derivatives | Adult | Female | Glioblastoma - metabolism | Retrospective Studies | Brain Neoplasms - mortality | Tumor Suppressor Proteins - metabolism | DNA Modification Methylases - metabolism | Brain Neoplasms - genetics | Isocitrate Dehydrogenase - genetics | Mutation - genetics | Disease Progression | Chemoradiotherapy, Adjuvant - methods | Antineoplastic Agents, Alkylating - therapeutic use | Glioblastoma - therapy | Disease-Free Survival | Magnetic Resonance Imaging | DNA Modification Methylases - genetics | Chromosomes, Human, 1-3 - genetics | Glioblastoma - pathology | Brain Neoplasms - therapy | Aged | Glioblastoma - mortality | Medical colleges | Gliomas | Nuclear radiation | GLIOMAS | DIAGNOSIS | PATIENTS | METHYLATION | PROMOTERS | RADIOLOGY AND NUCLEAR MEDICINE | MUTATIONS | CHEMOTHERAPY
Journal Article
The Lancet, ISSN 0140-6736, 02/2019, Volume 393, Issue 10172, pp. 678 - 688
Journal Article
Brain, ISSN 0006-8950, 10/2007, Volume 130, Issue 10, pp. 2596 - 2606
Journal Article
Acta Neuropathologica, ISSN 0001-6322, 5/2015, Volume 129, Issue 5, pp. 679 - 693
Journal Article
Journal of Translational Medicine, ISSN 1479-5876, 05/2018, Volume 16, Issue 1, pp. 1 - 9
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 7/2012, Volume 108, Issue 3, pp. 403 - 410
Journal Article
EMBO Molecular Medicine, ISSN 1757-4676, 01/2016, Volume 8, Issue 1, pp. 39 - 57
Glioblastoma multiforme (GBM) is treated by surgical resection followed by radiochemotherapy. Bevacizumab is commonly deployed for anti‐angiogenic therapy of... 
macrophage polarization | anti‐angiogenic therapy | glioblastoma | tumor angiogenesis | therapy resistance | Tumor angiogenesis | Anti-angiogenic therapy | Therapy resistance | Macrophage polarization | Glioblastoma | MEDICINE, RESEARCH & EXPERIMENTAL | anti-angiogenic therapy | NEWLY-DIAGNOSED GLIOBLASTOMA | OVARIAN-CANCER | SERUM ANGIOPOIETIN-2 | ANTIANGIOGENIC THERAPY | COLORECTAL-CANCER | TIE2-EXPRESSING MONOCYTES | POTENT ANTITUMOR | TUMOR-ASSOCIATED MACROPHAGES | DISEASE PROGRESSION | Mannose-Binding Lectins - metabolism | Bevacizumab - therapeutic use | Receptors, Vascular Endothelial Growth Factor - therapeutic use | Recombinant Fusion Proteins - pharmacology | Humans | Receptors, Vascular Endothelial Growth Factor - pharmacology | Recombinant Fusion Proteins - therapeutic use | Brain Neoplasms - pathology | Drug Resistance, Neoplasm | Vascular Endothelial Growth Factor A - metabolism | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Angiopoietin-2 - metabolism | Brain - metabolism | Lectins, C-Type - metabolism | Neoplasm Grading | Female | Brain Neoplasms - mortality | Macrophages - immunology | Angiopoietin-2 - blood | Disease Models, Animal | Endothelial Cells - metabolism | Mice, Inbred C57BL | Receptors, Cell Surface - metabolism | Mice, Transgenic | Macrophages - cytology | Brain Neoplasms - drug therapy | Up-Regulation - drug effects | Macrophages - metabolism | Animals | Signal Transduction - drug effects | Endothelial Cells - cytology | Glioblastoma - pathology | Brain - pathology | Mice | Angiopoietin-2 - antagonists & inhibitors | Glioblastoma - drug therapy | Glioblastoma - mortality | Analysis | Permeability | Angiogenesis inhibitors | T cells | Vascular endothelial growth factor | Health aspects | Glioblastoma multiforme | Endothelium | Cell survival | Angiopoietin | Therapeutic applications | Brain cancer | Lymphocytes T | Macrophages | Cancer therapies | Investigations | Endothelial cells | Bevacizumab | Angiogenesis | Genotype & phenotype | Brain research | Rodents | Growth factors | Tumors | Neuroscience | Pharmacology & Drug Discovery | Cancer
Journal Article
Neurosurgery, ISSN 0148-396X, 09/2017, Volume 64, Issue CN_suppl_1, pp. 236 - 237
Abstract INTRODUCTION Recurrent meningiomas often undergo a grade-progression to become atypical or malignant upon recurrence. Detailed study of progressive... 
Mutation | Tumors
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 2/2010, Volume 96, Issue 3, pp. 393 - 402
Journal Article
Journal Article